Manning Paul B 13D/13G Filings for Candel Therapeutics, Inc. (CADL)

Manning Paul B 13D and 13G filings for Candel Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
4:38 pm
Purchase
2021-07-29 13D Candel Therapeutics, Inc.
CADL
Manning Paul B 4,073,316
13.600%
4,073,316increase
(New Position)
Filing